Roche To Stop Selling Accutane In US

Law360, New York (June 29, 2009, 12:00 AM EDT) -- Hoffmann-La Roche Inc. has said it will stop making and selling the controversial acne medication Accutane, a drug that has been at the center of a slew of product liability suits, in the United States.

Roche said in a statement dated Friday that the decision to take the drug off the U.S. market was done for “business reasons” after reevaluating a number of the company's medications that are also available in generic form.

The decision to pull the drug was not made for safety reasons, the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.